Literature DB >> 10727131

A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma.

S Krishnaswami1, H Möllmann, H Derendorf, G Hochhaus.   

Abstract

A sensitive and selective LC-(APCI) MS/MS method capable of quantifying fluticasone propionate (FP) at levels down to 10 pg ml(-1) in human plasma is reported. The method was validated over a linear range from 10 to 1000 pg ml(-1) using a previously published solid-phase extraction procedure with a 13C3-labeled internal standard. The inter and intra batch precision (coefficient of variation) and accuracy (% bias) of the quality controls samples (20, 25, 50, 100, 200, 500 and 1000 pg ml(-1)) were less than 15 and 11%, respectively. The method is robust, rapid (analysis time of 2 min), selective and hence is ideally suited for pharmacokinetic investigations involving inhalation of therapeutic doses of FP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727131     DOI: 10.1016/s0731-7085(99)00246-0

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma.

Authors:  Kevin J Mortimer; Tim W Harrison; Yufei Tang; Kai Wu; Sarah Lewis; Srikumar Sahasranaman; Gunther Hochhaus; Anne E Tattersfield
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

2.  In vitro aqueous fluid-capacity-limited dissolution testing of respirable aerosol drug particles generated from inhaler products.

Authors:  Deepika Arora; Kumar A Shah; Matthew S Halquist; Masahiro Sakagami
Journal:  Pharm Res       Date:  2010-03-13       Impact factor: 4.200

3.  Systemic exposure to fluticasone MDI delivered through antistatic chambers.

Authors:  Mai K Elmallah; Yasmeen Khan; Guenther Hochhaus; Jonathan J Shuster; Leslie Hendeles
Journal:  J Allergy Clin Immunol       Date:  2011-07-23       Impact factor: 10.793

4.  Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction.

Authors:  Kevin J Mortimer; Anne E Tattersfield; Yufei Tang; Kai Wu; Sarah Lewis; Gunther Hochhaus; Tim W Harrison
Journal:  Br J Clin Pharmacol       Date:  2007-08-15       Impact factor: 4.335

5.  HPTLC-densitometric method for simultaneous determination of salmeterol xinafoate and fluticasone propionate in dry powder inhalers.

Authors:  Lantider Kasaye; Ariaya Hymete; Abdel-Maaboud I Mohamed
Journal:  Saudi Pharm J       Date:  2010-05-31       Impact factor: 4.330

6.  Use of PBPK Modeling To Evaluate the Performance of Dissolv It, a Biorelevant Dissolution Assay for Orally Inhaled Drug Products.

Authors:  Mireille Hassoun; Maria Malmlöf; Otto Scheibelhofer; Abhinav Kumar; Sukhi Bansal; Ewa Selg; Mattias Nowenwik; Per Gerde; Snezana Radivojev; Amrit Paudel; Sumit Arora; Ben Forbes
Journal:  Mol Pharm       Date:  2019-02-15       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.